GS0421: Research and development in the field of pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer; research and development of pharmaceuticals for the treatment of hematologic diseases; research and development of pharmaceuticals for the treatment of inflammations; research and development of pharmaceuticals for the treatment of immune-mediated conditions; medical research in the fields of oncology, immunology and immune-oncology, inflammation, and immune-mediated diseases
Case File Event Statements
10/16/2023 - a year ago
18 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDType:MAB6
10/16/2023 - a year ago
17 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
3/14/2023 - a year ago
16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM